Skip to main content
 

Here's a fun story from 2014 about the guy with the $750 drug. Could it be a short selling setup? http://www.bloomberg.com/bw/articles/2014-04-17/retrophins-martin-shkreli-the-biotech-short-seller-w...

· Statuses · Share this post

Email me: ben@werd.io

Signal me: benwerd.01

Werd I/O © Ben Werdmuller. The text (without images) of this site is licensed under CC BY-NC-SA 4.0.